Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Multiparametric Ultrasound for the Noninvasive Diagnosis of Porto-sinusoidal Vascular Liver Disorder [NA]
A clinical trial protocol update evaluating multiparametric ultrasound for noninvasive diagnosis of Porto-sinusoidal vascular liver disorder…
-
EMA approval · 2026-03-24EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
Qaialdo is a spironolactone product by Lipomed GmbH that has been authorized in the EU. Indications include edema, heart failure, liver cirr…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism [NA]
Clinical trial update describing a planned comparison of LSD versus TIPS for cirrhotic portal hypertension with bleeding and hypersplenism; …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Association of Sarcopenia With Rocuronium Use in Liver Transplant Recipients [NA]
A completed clinical trial update investigating the association between sarcopenia and rocuronium use in liver transplant recipients.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: EUS Elastography for Predicting Cirrhotic-related Complications
An ongoing clinical trial evaluating endoscopic ultrasound elastography to predict cirrhosis-related complications; the study is currently a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems [Phase 2]
Phase 2 trial evaluating the efficacy and safety of lemborexant for sleep problems in patients with liver cirrhosis; the study status is com…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study [NA]
A multicenter randomized controlled trial evaluating whether Fufang Biejiaruangan plus antiviral therapy reduces hepatocellular carcinoma in…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal Bleeding
A clinical trial investigating whether physiological parameters can predict prognosis in patients with liver cirrhosis and gastrointestinal …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment [Phase 1]
A Phase 1 safety evaluation of a mesenchymal stem cell-based therapy for liver cirrhosis; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study [NA]
A prospective pilot study evaluating fiber-optic navigation to guide transjugular intrahepatic portosystemic shunt (TIPS) creation. The stud…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Copper Supplementation in Cirrhosis [NA]
An ongoing University of Washington clinical trial is evaluating copper supplementation in patients with liver disease, including cirrhosis …
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis
A completed clinical trial assesses safety and efficacy of the atezolizumab‑bevacizumab combination versus tyrosine kinase inhibitors in pat…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis. [NA]
A clinical trial comparing carvedilol plus midodrine versus carvedilol alone to prevent early rebleed in patients with liver cirrhosis; the …
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis [Phase 4]
Phase 4 clinical trial evaluating Simcyp-guided dosing of simvastatin in patients with liver cirrhosis and portal hypertension has been comp…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects [Phase 1]
A Phase 1 clinical trial evaluating recombinant human serum albumin in patients with liver cirrhosis and ascites has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites [NA]
A completed pediatric trial compares midodrine plus albumin versus midodrine alone to prevent cirrhosis-related complications in children wi…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
This clinical trial is investigating host risk factors for invasive pulmonary aspergillosis in patients with liver cirrhosis, aiming to unde…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis [Phase 4]
Phase 4 clinical trial update reporting dose optimization of sitagliptin and duloxetine in patients with diabetic cirrhosis. The study statu…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
This clinical trial update analyzes the efficacy and survival prediction of transjugular intrahepatic portosystemic shunt (TIPS) in patients…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
A clinical trial update describing a study on predictors of decompensation, acute-on-chronic liver failure and mortality in liver cirrhosis,…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B [Phase 1, Phase 2]
This entry reports a Phase 1/2 clinical trial using umbilical cord mesenchymal stem cells to treat liver cirrhosis caused by chronic hepatit…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis
This clinical trial evaluates hepatitis A immunity and the immunogenicity of a single-dose HAV vaccine in patients with cirrhosis; the study…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis [Phase 1]
Ongoing Phase 1 clinical trial evaluating direct oral anticoagulants rivaroxaban and apixaban in patients with liver cirrhosis (recruiting).
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Role of ICCO Score in Predicting Outcome in ICU Patients
A completed clinical trial evaluated whether the ICCO score can predict outcomes in ICU patients with liver cirrhosis.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis [Phase 3]
A Phase 3 trial evaluating fecal microbiota transplantation to improve outcomes in liver cirrhosis is currently recruiting.